The activation of α1-adrenoceptors is implicated in the antidepressant-like effect of creatine in the tail suspension test

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 44, Issue , 2013, Pages 39-50

  Cunha, Mauricio P ^a   Pazini, Francis L ^a   Oliveira, Ágatha ^a   Bettio, Luis E B ^a   Rosa, Julia M ^a   Machado, Daniele G ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Antidepressant; Creatine; Noradrenaline; Tail suspension test

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; AMITRIPTYLINE; CREATINE; IMIPRAMINE; METIROSINE; NORADRENALIN TRANSPORTER; PHENYLEPHRINE; PRAZOSIN; REBOXETINE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG POTENTIATION; IMMOBILIZATION; MALE; MOUSE; NEUROMODULATION; NONHUMAN; NORADRENERGIC SYSTEM; PSYCHOLOGIC TEST; TAIL SUSPENSION TEST; TREATMENT RESPONSE;

ADRENERGIC AGENTS; ALPHA-METHYLTYROSINE; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; CREATINE; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ENZYME INHIBITORS; EXPLORATORY BEHAVIOR; HINDLIMB SUSPENSION; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; RECEPTORS, ADRENERGIC, ALPHA-1; TIME FACTORS;

EID: 84873893734     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.01.014     Document Type: Article

References (93)

1. Allen P.J., D'Anci K.E., Kanarek R.B., Renshaw P.F. Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner. Neuropsychopharmacology 2010, 35:534-546.
2. Allen P.J., D'Anci K.E., Kanarek R.B., Renshaw P.F. Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats. Pharmacol Biochem Behav 2012, 101:588-601.
3. Amital D., Vishne T., Roitman S., Kotler M., Levine J. Open study of creatine monohydrate in treatment-resistant posttraumatic stress disorder. J Clin Psychiatry 2006, 67:836-837.
4. Andres R.H., Ducray A.D., Schlattner U., Wallimann T., Widmer H.R. Functions and effects of creatine in the central nervous system. Brain Res Bull 2008, 76:329-343.
5. Assis L.C., Rezin G.T., Comim C.M., Valvassori S.S., Jeremias I.C., Zugno A.I., et al. Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats. Rev Bras Psiquiatr 2009, 31:247-252.
6. Binfaré R.W., Rosa A.O., Lobato K.R., Santos A.R., Rodrigues A.L.S. Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:530-540.
7. Blasi G., Bertolino A., Brudaglio F., Sciota D., Altamura M., Antonucci N., et al. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study. Psychiatry Res 2004, 131:95-105.
8. Bönisch H., Brüss M. The norepinephrine transporter in physiology and disease. Handb Exp Pharmacol 2006, 175:485-524.
9. Bremner J.D., Vythilingam M., Ng C.K., Vermetten E., Nazeer A., Oren D.A., et al. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. JAMA 2003, 289:3125-3134.
10. Brunello N., Mendlewicz J., Kasper S., Leonard B., Montgomery S., Nelson J., et al. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. Eur Neuropsychopharmacol 2002, 12:461-475.
11. Bunney W.E., Davis J.M. Norepinephrine in depressive reactions. Arch Gen Psychiatry 1965, 13:483-494.
12. Caldarone B.J., Harrist A., Cleary M.A., Beech R.D., King S.L., Picciotto M.R. High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation. Biol Psychiatry 2004, 56:657-664.
13. Capra J.C., Cunha M.P., Machado D.G., Zomkowski A.D., Mendes B.G., Santos A.R., et al. Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems. Eur J Pharmacol 2010, 643:232-238.
14. Carboni E., Tanda G.L., Frau R., Di Chiara G. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 1990, 55:1067-1070.
15. Cardoso C.C., Lobato K.R., Binfaré R.W., Ferreira P.K., Rosa A.O., Santos A.R., et al. Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:235-242.
16. Carrodi H., Fuxe K. The effects of imipramine on central monoamine neurones. J Pharm Pharmacol 1968, 20:230-231.
17. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005, 29:571-625.
18. Cunha M.P., Machado D.G., Bettio L.E., Capra J.C., Rodrigues A.L.S. Interaction of zinc with antidepressants in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1913-1920.
19. Cunha M.P., Machado D.G., Capra J.C., Jacinto J., Bettio L.E., Rodrigues A.L.S. Antidepressant-like effect of creatine in mice involves dopaminergic activation. J Psychopharmacol 2012, 26:1489-1501.
20. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004, 61:450-458.
21. Danysz W., Kostowski W., Kozak W., Hauptmann M. On the role of noradrenergic neurotransmission in the action of desipramine and amitriptyline in animal models of depression. Pol J Pharmacol Pharm 1986, 38:285-298.
22. DeBellis M., Geracioti T., Altemus M. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers. Biol Psychiatry 1993, 33:636-641.
23. Deicken R.F., Pegues M.P., Anzalone S., Feiwell R., Soher B. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am J Psychiatry 2003, 160:873-882.
24. Delgado P.L., Miller H.L., Salomon R.M., Licinio J., Heninger G.R., Gelenberg A.J., et al. Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull 1993, 29:389-396.
25. Delgado P.L., Moreno F.A., Onate L., Gelenberg A.J. Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients. Int J Neuropsychopharmacol 2002, 5:63-66.
26. Deupree J.D., Reed A.L., Bylund D.B. Differential effects of the tricyclic antidepressant desipramine on the density of adrenergic receptors in juvenile and adult rats. J Pharmacol Exp Ther 2007, 321:770-776.
27. Di Cesare M.L., Vivoli E., Salvicchi A., Schiavone N., Koverech A., Messano M., et al. Antidepressant-like effect of artemin in mice: a mechanism for acetyl-l-carnitine activity on depression. Psychopharmacology 2011, 21:347-356.
28. 31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depression. Int J Geriatr Psychiatry 2009, 24:788-797.
29. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates 1997, Academic Press, San Diego. 1st ed.
30. Haenisch B., Bönisch H. Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters. Pharmacol Ther 2011, 129:352-368.
31. Hajós M., Fleishaker J.C., Filipiak-Reisner J.K., Brown M.T., Wong E.H. The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile. CNS Drug Rev 2004, 10:23-44.
32. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 1957, 12:12-15.
33. Herring N.R., Schaefer T.L., Tang P.H., Skelton M.R., Lucot J.P., Gudelsky G.A., et al. Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats. BMC Neurosci 2008, 9:49.
34. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996, 17:187-205.
35. Hroudova J., Fisar Z. Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers. Neuro Endocrinol Lett 2010, 31:336-342.
36. Javaid J.I., Hendricks K., Davis J.M. Alpha 1-acid glycoprotein involvement in high affinity binding of tricyclic antidepressants to human plasma. Biochem Pharmacol 1983, 32:1149-1153.
37. Jesse C.R., Wilhelm E.A., Bortolatto C.F., Nogueira C.W. Evidence for the involvement of the noradrenergic system, dopaminergic and imidazoline receptors in the antidepressant-like effect of tramadol in mice. Pharmacol Biochem Behav 2010, 95:344-350.
38. Kasper S., el Giamal N., Hilger E. Reboxetine: the first selective noradrenaline re-uptake inhibitor. Expert Opin Pharmacother 2000, 1:771-782.
39. Kaster M.P., Raupp I., Binfaré R.W., Andreatini R., Rodrigues A.L.S. Antidepressant-like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of the noradrenergic system. Eur J Pharmacol 2007, 565:119-124.
40. Kato T., Takahashi S., Shioiri T., Inubushi T. Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 1992, 26:223-230.
41. Ketter T.A., Kimbrell T.A., George M.S., Dunn R.T., Speer A.M., Benson B.E., et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 2001, 49:97-109.
42. Khazaal, Fresard E., Rabia S., Apfeldorfer G., Zullino D. Prise de poids et antipsychotiques: investigation et traitement de la restriction cognitive. Etude préliminaire. J Thér Comport Cogn 2005, 15:22-26.
43. Kim S.Y., Lee Y.J., Kim H., Lee D.W., Woo D.C., Choi C.B., et al. Desipramine attenuates forced swim test-induced behavioral and neurochemical alterations in mice: an in vivo (1)H-MRS study at 9.4T. Brain Res 2010, 1348:105-113.
44. Kitada Y., Miyauchi T., Kanazawa Y., Nakamichi H., Satoh S. Involvement of alpha- and beta 1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test. Neuropharmacology 1983, 22:1055-1060.
45. Klimek V., Zak-Knapik J., Maj J. Antidepressants given repeatedly increase the alpha 1-adrenoceptor agonist affinity in the rat brain. Pol J Pharmacol Pharm 1991, 43:347-352.
46. Knox D., Perrine S.A., George S.A., Galloway M.P., Liberzon I. Single prolonged stress decreases glutamate, glutamine, and creatine concentrations in the rat medial prefrontal cortex. Neurosci Lett 2010, 480:16-20.
47. Kondo D.G., Sung Y.H., Hellem T.L., Fiedler K.K., Shi X., Jeong E.K., et al. Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study. J Affect Disord 2011, 135:354-361.
48. Laursen S.E., Belknap J.K. Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods 1986, 16:355-357.
49. Lipinski J.F., Cohen B.M., Zubenko G.S., Waternaux C.M. Adrenoceptors and the pharmacology of affective illness: a unifying theory. Life Sci 1987, 40:1947-1963.
50. Machado D.G., Kaster M.P., Binfaré R.W., Dias M., Santos A.R., Pizzolatti M.G., et al. Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:421-428.
51. Machado D.G., Bettio L.E., Cunha M.P., Santos A.R., Pizzolatti M.G., Brighente I.M., et al. Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Eur J Pharmacol 2008, 587:163-168.
52. Machado D.G., Bettio L.E., Cunha M.P., Capra J.C., Dalmarco J.B., Pizzolatti M.G., et al. Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:642-650.
53. Magni D.V., Oliveira M.S., Furian A.F., Fiorenza N.G., Fighera M.R., Ferreira J., et al. Creatine decreases convulsions and neurochemical alterations induced by glutaric acid in rats. Brain Res 2007, 1185:336-345.
54. Maj J., Klimek V., Nowak G. Antidepressant drugs given repeatedly increase binding to alpha 1-adrenoceptors in the rat cortex. Eur J Pharmacol 1985, 119:113-116.
55. Maj J., Rogóz Z., Dlaboga D., Dziedzicka-Wasylewska M. Pharmacological effects of milnacipran, a new antidepressant, given repeatedly on the alpha1-adrenergic and serotonergic 5-HT2A systems. J Neural Transm 2000, 107:1345-1359.
56. Masuda Y., Ohnuma S., Sugiyama T. Alpha 2-adrenoceptor activity induces the antidepressant-like glycolipid in mouse forced swimming. Methods Find Exp Clin Pharmacol 2001, 23:19-21.
57. Mayorga A.J., Dalvi A., Page M.E., Zimov-Levinson S., Hen R., Lucki I. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. J Pharmacol Exp Ther 2001, 298:1101-1107.
58. Menkes D.B., Aghajanian G.K., McCall R.B. Chronic antidepressant treatment enhances alpha-adrenergic and serotonergic responses in the facial nucleus. Life Sci 1980, 27:45-55.
59. Menkes D.B., Aghajanian G.K., Gallager D.W. Chronic antidepressant treatment enhances agonist affinity of brain alpha 1-adrenoceptors. Eur J Pharmacol 1983, 87:35-41.
60. Miller H.L., Delgado P.L., Salomon R.M., Berman R., Krystal J.H., Heninger G.R., et al. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry 1996, 53:117-128.
61. Miller H.L., Delgado P.L., Salomon R.M., Heninger G.R., Charney D.S. Effects of alpha-methyl-para-tyrosine (AMPT) in drug-free depressed patients. Neuropsychopharmacology 1996, 14:151-157.
62. Nowak G., Przegaliński E. Effect of repeated treatment with antidepressant drugs and electroconvulsive shock (ECS) on [3H]prazosin binding to different rat brain structures. J Neural Transm 1988, 71:57-64.
63. O'Leary O.F., Bechtholt A.J., Crowley J.J., Hill T.E., Page M.E., Lucki I. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology 2007, 192:357-371.
64. Oliveira M.S., Furian A.F., Fighera M.R., Fiorenza N.G., Ferreira J., Rubin M.A., et al. The involvement of the polyamines binding sites at the NMDA receptor in creatine-induced spatial learning enhancement. Behav Brain Res 2008, 187:200-204.
65. Orzi F., Passarelli F., Diana G., Fieschi C. Effects of single and repeated electroconvulsive shock on local cerebral glucose utilization in the conscious rat. Brain Res 1987, 423:144-148.
66. Papakostas G.I. Evidence for S-adenosyl-l-methionine (SAM-e) for the treatment of major depressive disorder. J Clin Psychiatry 2009, 70:18-22.
67. Pettegrew J.W., Levine J., Gershon S., Stanley J.A., Servan-Schreiber D., Panchalingam K., et al. 31P-MRS study of acetyl-l-carnitine treatment in geriatric depression: preliminary results. Bipolar Disord 2002, 4:61-66.
68. Potter W.Z., Scheinin M., Golden R.N., Rudorfer M.V., Cowdry R.W., Calil H.M., et al. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites. Arch Gen Psychiatry 1985, 42:1171-1177.
69. Pulvirenti G., Valerio C., Spadaro F., D'Agata V., Freni V., Nardo L., et al. Acetylcarnitine reduces the immobility of rats in a despair test (constrained swim). Behav Neural Biol 1990, 54:110-114.
70. Rambo LM, Ribeiro LR, Della-Pace ID, Stamm DN, da Rosa Gerbatin R, Prigol M, et al. Acute creatine administration improves mitochondrial membrane potential and protects against pentylenetetrazol-induced seizures. Amino Acids in press.
71. Rehavi M., Ramot O., Yavetz B., Sokolovsky M. Amitriptyline: long-term treatment elevates alpha-adrenergic and muscarinic receptor binding in mouse brain. Brain Res 1980, 194:443-453.
72. Réus G.Z., Stringari R.B., Rezin G.T., Fraga D.B., Daufenbach J.F., Scaini G., et al. Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain. J Neural Transm 2012, 119:481-491.
73. Richelson E., Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 1984, 104:277-286.
74. Rogóz Z. Potentiation of the antidepressant-like effect of desipramine or reboxetine by metyrapone in the forced swimming test in rats. Pharmacol Rep 2009, 61:1173-1178.
75. Roitman S., Green T., Osher Y., Karni N., Levine J. Creatine monohydrate in resistant depression: a preliminary study. Bipolar Disord 2007, 9:754-758.
76. Royes L.F., Fighera M.R., Furian A.F., Oliveira M.S., Myskiw J.de C., Fiorenza N.G., et al. Effectiveness of creatine monohydrate on seizures and oxidative damage induced by methylmalonate. Pharmacol Biochem Behav 2006, 83:136-144.
77. Rump L.C., Majewski H. Modulation of norepinephrine release through alpha 1- and alpha 2-adrenoceptors in rat isolated kidney. J Cardiovasc Pharmacol 1987, 9:500-507.
78. Samson A.C., Meisenzahl E., Scheuerecker J., Rose E., Schoepf V., Wiesmann M., et al. Brain activation predicts treatment improvement in patients with major depressive disorder. J Psychiatr Res 2011, 45:1214-1222.
79. Santos P.M., Scaini G., Rezin G.T., Benedet J., Rochi N., Jeremias G.C., et al. Brain creatine kinase activity is increased by chronic administration of paroxetine. Brain Res Bull 2009, 80:327-330.
80. Scaini G., Santos P.M., Benedet J., Rochi N., Gomes L.M., Borges L.S., et al. Evaluation of Krebs cycle enzymes in the brain of rats after chronic administration of antidepressants. Brain Res Bull 2010, 82:224-227.
81. Silveri M.M., Parow A.M., Villafuerte R.A., Damico K.E., Goren J., Stoll A.L., et al. S-adenosyl-l-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects. Biol Psychiatry 2003, 54:833-839.
82. Smeland O.B., Meisingset T.W., Borges K., Sonnewald U. Chronic acetyl-l-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy mice. Neurochem Int 2012, 61:100-107.
83. Souza M.A., Magni D.V., Guerra G.P., Oliveira M.S., Furian A.F., Pereira L., et al. Involvement of hippocampal CAMKII/CREB signaling in the spatial memory retention induced by creatine. Amino Acids 2012, 43:2491-2503.
84. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
85. Stone E.A., Quartermain D. Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression. Biol Psychiatry 1999, 46:1287-1300.
86. Tanda G., Carboni E., Frau R., Di Chiara G. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?. Psychopharmacology 1994, 115:285-288.
87. Verheij M.M., Cools A.R. Accumbal noradrenaline that contributes to the alpha-adrenoceptor-mediated release of dopamine from reserpine-sensitive storage vesicles in the nucleus accumbens is derived from alpha-methyl-para-tyrosine-sensitive pools. J Neural Transm 2009, 116:389-394.
88. Vetulani J., Antkiewicz-Michaluk L., Rokosz-Pelc A., Pilc A. Alpha up-beta down adrenergic regulation: a possible mechanism of action of antidepressant treatments. Pol J Pharmacol Pharm 1984, 36:231-248.
89. Vetulani J., Nalepa I. Antidepressants: past, present and future. Eur J Pharmacol 2000, 405:351-363.
90. Volz H.P., Rzanny R., Riehemann S., May S., Hegewald H., Preussler B., et al. 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients. Eur Arch Psychiatry Clin Neurosci 1998, 248:289-295.
91. Yamamoto B.K., Novotney S. Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem 1998, 71:274-280.
92. Yi L.T., Xu H.L., Feng J., Zhan X., Zhou L.P., Cui C.C. Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin. Physiol Behav 2011, 102:1-6.
93. Zhang W.P., Ouyang M., Thomas S.A. Potency of catecholamines and other l-tyrosine derivatives at the cloned mouse adrenergic receptors. Neuropharmacology 2004, 47:438-449.